Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Gevaert

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Allergy and Clinical Immunology|August 16, 2024
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNPClaus Bachert, Asif H Khan, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2017
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trialClaus Bachert, Ana R Sousa, Valerie J Lund, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory StudiesBob Geng, Claus Bachert, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2021
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trialClaus Bachert, Joseph K Han, Martin Y Desrosiers, et al.
The Journal of Allergy and Clinical Immunology|June 11, 2016
The quest for autoreactive antibodies in nasal polypsEls De Schryver, Lien Calus, Henryk Bonte, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 19, 2021
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthmaTanya M Laidlaw, Claus Bachert, Nikhil Amin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2021
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal PolypsJoaquim Mullol, Claus Bachert, Nikhil Amin, et al.
Rhinology|November 1, 2019
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNPClaus Bachert, S James Zinreich, Peter W Hellings, et al.
Allergy|July 1, 2026
Surgical Management of Non-Allergic Rhinitis-An EAACI Task Force Position PaperMarie Lundberg, Julie van Waterschoot, Mathilde Moyaert, et al.
Lancet (London, England)|March 4, 2025
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trialsPhilippe Gevaert, Martin Desrosiers, Marjolein Cornet, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Allergy and Clinical Immunology|August 16, 2024
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNPClaus Bachert, Asif H Khan, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2017
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trialClaus Bachert, Ana R Sousa, Valerie J Lund, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory StudiesBob Geng, Claus Bachert, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2021
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trialClaus Bachert, Joseph K Han, Martin Y Desrosiers, et al.
The Journal of Allergy and Clinical Immunology|June 11, 2016
The quest for autoreactive antibodies in nasal polypsEls De Schryver, Lien Calus, Henryk Bonte, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 19, 2021
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthmaTanya M Laidlaw, Claus Bachert, Nikhil Amin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2021
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal PolypsJoaquim Mullol, Claus Bachert, Nikhil Amin, et al.
Rhinology|November 1, 2019
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNPClaus Bachert, S James Zinreich, Peter W Hellings, et al.
Allergy|July 1, 2026
Surgical Management of Non-Allergic Rhinitis-An EAACI Task Force Position PaperMarie Lundberg, Julie van Waterschoot, Mathilde Moyaert, et al.
Lancet (London, England)|March 4, 2025
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trialsPhilippe Gevaert, Martin Desrosiers, Marjolein Cornet, et al.
Pageof 15